2010年度

●Blood-brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux.

Toyofumi Suzuki, Mariko Miyata, Chika Zaima, Takayuki Furuishi, Toshiro Fukami, Fumihiko Kugawa, Kazuo Tomono
J. Pharm. Sci., 99 (1), 413-421, 2010

●Homogeneous nanoparticles to enhance the efficiency of a hydrophobic drug, antihyperlipidemic probucol, characterized by solid-state NMR.

Takeshi Io, Toshiro Fukami, Kazutoshi Yamamoto, Toyofumi Suzuki, Jiadi Xu, Kazuo Tomono, Ayyalusamy Ramamoorthy
Mol. Pharmceutics, 7 (1), 299-305, 2010

●Prediction of solubilities of pharmaceutical compounds in water+co-solvent systems using an activity coefficient model.

Hiroyuki Matsuda, Kenta Kaburagi, Kiyofumi Kurihara, Katsumi Tochigi, Kazuo Tomono
Fluid Phase Eqilib, 290 (1-2), 153-157, 2010

●Ascorbyl dipalmitate/PEG-lipid nanoparticles as a novel carrier for hydrophobic drugs.

Kunikazu Moribe, Sunao Maruyama, Yutaka Inoue, Toyofumi Suzuki, Toshiro Fukami, Kazuo Tomono, Kenjirou Higashi, Yuichi Tozuka, Keiji Yamamoto
Int. J. Pharm., 387 (1-2), 236-243, 2010

●Synergistic effect of isopropyl myristate and glyceryl monocaprylate on the skin permeation of pentazocine.

Takayuki Furuishi, Toshiro Fukami, Toyofumi Suzuki, Kozo Takayama, Kazuo Tomono
Biol. Pharm. Bull., 33 (2), 294-300, 2010

●Involvement of an influx transporter in the blood-brain barrier transport of naloxone.

Toyofumi Suzuki, Aya Ohmuro, Mariko Miyata, Takayuki Furuishi, Shinji Hidaka, Fumihiko Kugawa, Toshiro Fukami, Kazuo Tomono
Biopharm. Drug Dispos., 31 (4), 243-252, 2010

●Powdered formulation of liquid oil terpenoid included in cyclodextrins for chemical stabilization and improved handling.

Noriko Saruta, Toshiro Fukami, Takayuki Furuishi, Toyofumi Suzuki, Kazuo Tomono
Adv. Powder Tech., 21 (3), 326-330, 2010

●Enhanced solubility of fullerene (C60) in water by inclusion complexation with cyclomaltononaose (δ-CD) using a cogrinding method.

Takayuki Furuishi, Yasunao Ohmachi, Toshiro Fukami, Hiromasa Nagase, Toyofumi Suzuki, Tomohiro Endo, Haruhisa Ueda, Kazuo Tomono
J. Incl. Phenom. Macrocycl. Chem., 67 (1-2), 233-239, 2010

●Effects of kaempferol on the mechanisms of drug resistance in the human glioblastoma cell line T98G.

Akira Nakatsuma, Toshiro Fukami, Toyofumi Suzuki, Takayuki Furuishi, Kazuo Tomono, Shinji Hidaka
Pharmazie, 65 (5), 379-383, 2010

●アセトアミノフェン含有一般用医薬品の物理薬剤学的安定性

太田 美鈴, 高橋 由里, 深水 啓朗, 伴野 和夫, 岩田 政則, 日髙 慎二
医療薬学, 36(6), 425-435, 2010

●Effect of β-cyclodextrin on the degradation rate of amoxicillin in acidic solution.

Shinji Hidaka, Tadakazu Tokumura, Kazuo Tomono, Toyofumi Suzuki, Haruhisa Ueda, Tsuneji Nagai, Masashi Nagaoka, Rieko Nakane, Yoshiharu Machida
YAKUGAKU ZASSHI, 130 (6), 889-893, 2010

●表面自由エネルギーの低い素材からなるメートグラスに対するシロップ剤の付着残存性

山本 佳久, 鈴木 豊史, 橋崎　要, 小倉 雅男, 梅田 由紀子, 日髙 慎二, 深水 啓朗, 伴野 和夫
薬学雑誌, 130(8), 1085-1091, 2010